Showing results (91-100 of 115) with videos related to
Sort By:
Pageof 12
Cancer Discovery|August 21, 2021
PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by NSD2 Mutation in Pediatric Acute Lymphoblastic LeukemiaJianping Li, Julia Hlavka-Zhang, Jonathan H Shrimp, et al.Cancer Discovery|September 15, 2019
GATA3-Controlled Nucleosome Eviction Drives MYC Enhancer Activity in T-cell Development and LeukemiaLaura Belver, Alexander Y Yang, Robert Albero, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2010
Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemiaAlejandro Gutierrez, Suzanne E Dahlberg, Donna S Neuberg, et al.Cell Reports|April 20, 2022
Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphomaJose R Cortes, Ioan Filip, Robert Albero, et al.Blood|October 22, 2024
Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutationAnita Kumar, Jacob Soumerai, Jeremy S Abramson, et al.Nature Genetics|September 6, 2011
Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemiaPriscila P Zenatti, Daniel Ribeiro, Wenqing Li, et al.Cancer Discovery|January 26, 2022
Targeting S100A9-ALDH1A1-Retinoic Acid Signaling to Suppress Brain Relapse in EGFR-Mutant Lung CancerAnup Kumar Biswas, Seoyoung Han, Yifan Tai, et al.The Journal of Clinical Investigation|October 31, 2017
Pharmacological inhibition of the transcription factor PU.1 in leukemiaIléana Antony-Debré, Ananya Paul, Joana Leite, et al.Nature Communications|March 10, 2023
The TINCR ubiquitin-like microprotein is a tumor suppressor in squamous cell carcinomaLucia Morgado-Palacin, Jessie A Brown, Thomas F Martinez, et al.Pageof 12